Nat Brinn

Nat Brinn is a Founding Partner at VC23 Investors and Vital Venture Capital, based in Avon, Connecticut. Prior to his venture capital career, he served as the Chief Executive Officer of HSA Bank, the largest specialty bank for health savings accounts in the United States. Over a 25-year career in private investments, acquisitions, and business management, Brinn has executed 25 early-stage investments primarily focused on biotechnology, diagnostics, and life science tools. His portfolio includes successful exits and strategic investments in prominent life sciences companies such as Twist Biosciences, 10X Genomics, and Ginkgo Bioworks. He has also backed specialized ventures like CD Diagnostics, targeting sectors ranging from proteomics and AI-assisted genomics to modular biomanufacturing. Brinn currently focuses on identifying and scaling early-stage life sciences enterprises that develop advanced laboratory instrumentation, data analytics, and diagnostic devices.